Reiley Pharmaceuticals
San Jose, US · Founded 2014 · Delaware corporation
Founders & leadership
BM
B Michael SilberExecutive
Board
JD
Jeff DunnBoard director
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 6 of 7 rounds · 2014–2024
▶$97.7KraisedJun 2024 · 6 investors · PharmaceuticalsRule 506(b)
▶$97.7KraisedJun 2024 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Keith ValentineDirector
- Jeffrey DunnDirector
- B. Michael SilberDirector
- Donald KiepertExecutive Officer, Director
- Offering amount
- $247.1K
- Amount sold
- $97.7K
- Minimum investment
- $2.5K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedOct 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$100KraisedOct 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey DunnDirector
- Keith ValentineDirector
- B. Michael SilberExecutive Officer, Director
- Offering amount
- $447.1K
- Amount sold
- $100K
- Minimum investment
- $10K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedAug 2020 · 27 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedAug 2020 · 27 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Keith ValentineDirector
- Jeffrey DunnDirector
- B. Michael SilberExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KofferedOct 2019 · PharmaceuticalsRule 506(b)
▶$400KofferedOct 2019 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark ReileyPromoter
- Keith ValentineDirector
- Jeff DunnDirector
- B Michael SilberExecutive Officer
- Offering amount
- $400K
- Minimum investment
- $3K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.2MraisedNov 2017 · 19 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedNov 2017 · 19 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeff DunnDirector
- B Michael SilberExecutive Officer
- Mark ReileyPromoter
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Minimum investment
- $12.5K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.1MraisedJan 2016 · 20 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedJan 2016 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark ReileyPromoter
- B Michael SilberExecutive Officer
- Jeff DunnDirector
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- Minimum investment
- $20K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$980KraisedAug 2014 · 15 investors · PharmaceuticalsRule 506(b)
▶$980KraisedAug 2014 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeff DunnDirector
- B Michael SilberExecutive Officer
- Mark ReileyPromoter
- Offering amount
- $1.3M
- Amount sold
- $980K
- Minimum investment
- $50K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Reiley Pharmaceuticals raised?
- Reiley Pharmaceuticals has disclosed $4.5M raised across 6 of its 7 known rounds.
- Where is Reiley Pharmaceuticals headquartered?
- Reiley Pharmaceuticals is headquartered in San Jose, US.